StartsideRGEDF • OTCMKTS
add
Gedeon Richter Ord Shs
Forrige sluttkurs
27,17 $
Årsintervall
24,01 $ - 29,58 $
P/E-tall
-
Utbytte
-
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
| (HUF) | sep. 2024info | Endring år til år |
|---|---|---|
Omsetning | 216,73 mrd. | 14,95 % |
Driftskostnader | 94,69 mrd. | 10,59 % |
Nettoomsetning | 37,06 mrd. | −32,07 % |
Netto resultatmargin | 17,10 | −40,89 % |
Fortjeneste per aksje | — | — |
EBITDA | 76,39 mrd. | 23,89 % |
Faktisk avgiftssats | 19,13 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
| (HUF) | sep. 2024info | Endring år til år |
|---|---|---|
Kontant / kortsiktige inv. | 74,99 mrd. | −29,24 % |
Totale aktiva | 1,49 bill. | 9,53 % |
Totale passiva | 258,83 mrd. | −1,37 % |
Total egenkapital | 1,23 bill. | — |
Utestående aksjer | 182,62 mill. | — |
P/B-forhold | 0,00 | — |
Avkastning på aktiva | 10,29 % | — |
Avkastning på kapital | 11,59 % | — |
Kontantstrøm
Netto kontantstrøm
| (HUF) | sep. 2024info | Endring år til år |
|---|---|---|
Nettoomsetning | 37,06 mrd. | −32,07 % |
Kontantstrøm fra drift | 67,55 mrd. | 56,30 % |
Kontanter fra investering | −13,69 mrd. | 54,12 % |
Kontanter fra finansiering | −36,70 mrd. | −409,23 % |
Netto kontantstrøm | 17,12 mrd. | −34,71 % |
Fri kontantstrøm | 13,19 mrd. | 1 594,12 % |
Om
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
Administrerende direktør
Grunnlagt
1901
Nettsted
Ansatte
11 603
